Key find for early bladder cancer treatment

May 23, 2013

Aggressive forms of bladder cancer involve the protein PODXL – a discovery that could hold the key to improved treatment, according to researchers at Lund University, Uppsala University and KTH in Sweden.

"With better knowledge of this protein, we can better determine a patient's prognosis and see who needs more immediately and who can be given a milder treatment without a risk to their life. We can see at an early stage which patients are in the risk zone for cancer recurrence", said Karolina Boman, a doctoral student at the Division of Pathology at Lund University.

The study involved almost 500 men and women between the ages of 39 and 90. The patients with tumours containing the protein podocalyxin-like, PODXL, had an increased risk of a or of dying of the disease within two years – even in cases that were discovered early and only had superficial tumours.

"We have previously shown that the presence of this protein in the cell membrane of patients with colorectal cancer increases the risk of recurrence or of dying of the disease. Now we have seen the same thing in patients with .

The prognosis is poor even if the protein is only present in low concentrations", said Karolina Boman.

The researchers believe that the new findings about this protein could also be of use for other forms of cancer.

"We can no doubt utilise this for example for pancreatic cancer, and . It could also save society a lot of money, especially if in the future we could see which tumours contain the protein using a simple urine test. That is what we are going to look at now", said Karolina Boman.

Explore further: Coffee may help prevent breast cancer returning, study finds

More information: Boman, K. et al. Membranous expression of podocalyxin-like protein is an independent factor of poor prognosis in urothelial bladder cancer, British Journal of Cancer online 7 May 2013. doi: 10.1038/bjc.2013.215

Related Stories

Coffee may help prevent breast cancer returning, study finds

April 25, 2013
Drinking coffee could decrease the risk of breast cancer recurring in patients taking the widely used drug Tamoxifen, a study at Lund University in Sweden has found. Patients who took the pill, along with two or more cups ...

Genetic alterations linked with bladder cancer risk, recurrence, progression, and patient survival

March 25, 2013
A new analysis has found that genetic alterations in a particular cellular pathway are linked with bladder cancer risk, recurrence, disease progression, and patient survival. Published early online in Cancer, a peer- reviewed ...

Certain bladder-cancer patients may be at high risk of disease recurrence despite bladder removal

May 7, 2013
Patients with advanced bladder cancers that are surgically removed might need additional therapy to prevent recurrence in certain situations, a new UT Southwestern Medical Center study suggests.

Prostate cancer prognosis hope

October 29, 2012
Cancer of the prostate – the most common male cancer in the UK – presents in two distinct ways: a low-risk type, which may never cause any symptoms, and a high-risk form that needs treatment to prevent it spreading to ...

Scientists find promising new target for aggressive breast cancer

March 20, 2013
Women with triple-negative breast cancer are more likely to have high levels of the MET biomarker in their tumours, making it a good new target for cancer drugs according to research published in the British Journal of Cancer, ...

Scientists identify potential target to reduce progression of metastases

April 15, 2013
A team of researchers at the IRCM, led by Dr. Jean-François Côté, made an important discovery in breast cancer, which will published online this week by the scientific journal Proceedings of the National Academy of Sciences ...

Recommended for you

No dye: Cancer patients' gray hair darkened on immune drugs

July 21, 2017
Cancer patients' gray hair unexpectedly turned youthfully dark while taking novel drugs, and it has doctors scratching their heads.

Shooting the achilles heel of nervous system cancers

July 20, 2017
Virtually all cancer treatments used today also damage normal cells, causing the toxic side effects associated with cancer treatment. A cooperative research team led by researchers at Dartmouth's Norris Cotton Cancer Center ...

Molecular changes with age in normal breast tissue are linked to cancer-related changes

July 20, 2017
Several known factors are associated with a higher risk of breast cancer including increasing age, being overweight after menopause, alcohol intake, and family history. However, the underlying biologic mechanisms through ...

Immune-cell numbers predict response to combination immunotherapy in melanoma

July 20, 2017
Whether a melanoma patient will better respond to a single immunotherapy drug or two in combination depends on the abundance of certain white blood cells within their tumors, according to a new study conducted by UC San Francisco ...

Discovery could lead to better results for patients undergoing radiation

July 19, 2017
More than half of cancer patients undergo radiotherapy, in which high doses of radiation are aimed at diseased tissue to kill cancer cells. But due to a phenomenon known as radiation-induced bystander effect (RIBE), in which ...

Definitive genomic study reveals alterations driving most medulloblastoma brain tumors

July 19, 2017
The most comprehensive analysis yet of medulloblastoma has identified genomic changes responsible for more than 75 percent of the brain tumors, including two new suspected cancer genes that were found exclusively in the least ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.